Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.
Meulebrouck S, Scherrer V, Boutry R, Toussaint B, Vaillant E, Dechaume A, Loiselle H, Balkau B, Charpentier G, Franc S, Marre M, Baron M, Vaxillaire M, Derhourhi M, Boissel M, Froguel P, Bonnefond A.
Meulebrouck S, et al. Among authors: franc s.
Diabetologia. 2024 Feb;67(2):327-332. doi: 10.1007/s00125-023-06035-x. Epub 2023 Dec 5.
Diabetologia. 2024.
PMID: 38051360
Free PMC article.